Difficulty: Medium
Average Score: 76%
Practice
Pharmacodynamic properties of salmeterol include:
Correct answer
D
Rationale
In this question, the correct answer is D) Prolonged pharmacodynamic effects allowing twice-daily dosing.
The pharmacodynamic properties of salmeterol, a long-acting beta-agonist used in the treatment of respiratory conditions like asthma and COPD, include a prolonged duration of action. This allows for twice-daily dosing, making it convenient for patients to manage their condition effectively.
Option A) Tremor is not a pharmacodynamic property of salmeterol but can be seen with short-acting beta-agonists like albuterol due to their rapid onset of action.
Option B) Exacerbation of atrial dysrhythmias is not a known pharmacodynamic effect of salmeterol. Atrial dysrhythmias are more commonly associated with medications like digoxin or certain antiarrhythmic drugs.
Option C) Hyperkalemia is not a typical pharmacodynamic property of salmeterol. Instead, it is a potential side effect associated with the use of potassium-sparing diuretics or medications like ACE inhibitors.
In an educational context, understanding the pharmacodynamic properties of respiratory drugs is crucial for healthcare professionals to make informed decisions when managing patients with respiratory conditions. Knowing the specific effects of medications like salmeterol helps in optimizing treatment plans and ensuring patient safety and adherence.
The pharmacodynamic properties of salmeterol, a long-acting beta-agonist used in the treatment of respiratory conditions like asthma and COPD, include a prolonged duration of action. This allows for twice-daily dosing, making it convenient for patients to manage their condition effectively.
Option A) Tremor is not a pharmacodynamic property of salmeterol but can be seen with short-acting beta-agonists like albuterol due to their rapid onset of action.
Option B) Exacerbation of atrial dysrhythmias is not a known pharmacodynamic effect of salmeterol. Atrial dysrhythmias are more commonly associated with medications like digoxin or certain antiarrhythmic drugs.
Option C) Hyperkalemia is not a typical pharmacodynamic property of salmeterol. Instead, it is a potential side effect associated with the use of potassium-sparing diuretics or medications like ACE inhibitors.
In an educational context, understanding the pharmacodynamic properties of respiratory drugs is crucial for healthcare professionals to make informed decisions when managing patients with respiratory conditions. Knowing the specific effects of medications like salmeterol helps in optimizing treatment plans and ensuring patient safety and adherence.